Doctors warn against using Avastin for macular degeneration.
Kmietowicz
Zosia
Z
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D016527:Drug Costs; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000191:economics; D056687:Off-Label Use / Q000191:economics*; D009883:Ophthalmic Solutions / Q000009:adverse effects* / Q000191:economics; D000069579:Ranibizumab; D012307:Risk Factors; D006113:United Kingdom
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D009883:Ophthalmic Solutions; D000068258:Bevacizumab; D000069579:Ranibizumab